Skip to content

COVID-19 Virtual Care at Home

COVID-19 Virtual Care at Home

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04420182
Enrollment
817
Registered
2020-06-09
Start date
2020-08-17
Completion date
2022-02-04
Last updated
2022-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19

Keywords

COVID-19, SARS-CoV-2, VIRTUES, Virtual Care Management, Virtual Care, Patient Satisfaction, Anxiety, Emergency Visits, Oxygen Saturation, Quality of Life

Brief summary

This multicentre prospective cohort trial is designed to demonstrate effectiveness and efficiency of a virtual care model for the management of COVID-19 patients isolating at home. The investigators have reoriented existing technology and networks for this research project. The investigators are amplifying our existing virtual care platform VIRTUES, combining it with home monitoring of COVID-19 patients, to provide real-time evidence, harmonize data collection, and share data provincially to mitigate the impact of the rapid spread of the virus. The study will facilitate early detection of complications associated with the disease, treatment and management of COVID-19 patients at home. The research will be conducted provincially in Ontario. This initiative will provide evidence to inform clinical and health system management and public health response to COVID-19 patients isolating at home.

Interventions

OTHERVirtual Care at Home

Participants will have access to the VIRTUES platform for COVID-19 Virtual Care at Home

Sponsors

Cardiac Arrhythmia Network of Canada
CollaboratorOTHER
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Prospective non-randomized cohort study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All COVID-19 positive patients of age 18 or above * Participant must communicate in English or French language * An email address and account

Exclusion criteria

* Unable or unwilling to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
14 Day Patient Satisfaction Questionnaire14 daysThe primary outcome measure is patient satisfaction as measured from a patient satisfaction questionnaire at 14 days.

Secondary

MeasureTime frameDescription
Emergency Department Visits14 daysThe secondary outcome measures will include the number of patients that require an Emergency Department visits during the observation period of 14 days.
14 Day EQ-5D-5L Scores14 daysThe secondary outcome measures will include the health status measures of the EuroQuality of Life Five Dimensions (EQ-5D-5L) at 14 days. Scoring is Level 1 to 5 for each dimension; higher scores meaning worse health status.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026